RISING STARS: Targeting G protein-coupled receptors to regulate energy homeostasis. [PDF]
J Mol Endocrinol, 2023 Jamaluddin A, Gorvin CM.
europepmc +1 more source
Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials. [PDF]
Diabetes Obes MetabAlhazmi A, le Roux CW.
europepmc +1 more source
Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model. [PDF]
Menopause, 2021 Katri A +4 more
europepmc +1 more source
Amylin Revisited: A 5-Year Perspective on Its Emerging Role in the Treatment of Diabesity. [PDF]
J Obes Metab SyndrChung CW, Kim J.
europepmc +1 more source
DAILY PALO ALTO TIMES, 'J'l Ksn \V- IAN- *> 1912 PAGE THREE NOTICE OP COMMMSIOKKR'S' Company, a corporation, tbe above' 8AXB OF IIL.1L ESTATE OX! named defendants on tb* l.th day' 1-tilil.cu-sl Hi: or MORTGAGE. „, o1c* said] 1. ibe Superior Conn
core
Simultaneous partial volume correction and denoising of brain PET images, using transformers and transfer learning. [PDF]
EJNMMI ResKaviani S +4 more
europepmc +1 more source
TH.- end Ste Bhepptoff Hs ta Hrapetohse, art Oeariy Levra th. Mara monay to waaisd every ymr by women bnytos msdlera thing* under the eiclinerat of she targato hart thaa to trprat la .11 the gambling hen**, and rare track, cot togrtter.
core
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Front Endocrinol (Lausanne)Alhazmi A, le Roux CW.
europepmc +1 more source
Te Ow Sb-._-.-i 0*4. yoar popor wb*n tt arrt—a. U.i.n tor tbo carrier's whlati*. If aot aened by T.» aollfy Mr. t>H**g, -*-.»• IMS. tmes The Wether For-catt .AN f F..NCIBC0, Oct. ||—-fer Ihs Saffts Clara v.ll.,: Tonight and sun. fJsy lair: t—all.
core
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? [PDF]
Rev Endocr Metab DisordRyan DH.
europepmc +1 more source